Detalhe da pesquisa
1.
The T-box transcription factor brachyury behaves as a tumor suppressor in gliomas.
J Pathol
; 251(1): 87-99, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154590
2.
Evaluation of the prognostic potential of EGFL7 in pilocytic astrocytomas.
Neuropathology
; 41(1): 21-28, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191640
3.
Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas.
Cancers (Basel)
; 16(8)2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672598
4.
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways.
Sci Rep
; 13(1): 12424, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37528172
5.
Neuropathology of Pituitary Adenomas and Sellar Lesions.
Neurosurgery
; 88(5): 900-918, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476394
6.
Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology.
Cancers (Basel)
; 13(4)2021 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33673104
7.
The Carbonic Anhydrase Inhibitor E7070 Sensitizes Glioblastoma Cells to Radio- and Chemotherapy and Reduces Tumor Growth.
Mol Neurobiol
; 58(9): 4520-4534, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085182
8.
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589661
9.
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.
J Clin Oncol
; 38(29): 3407-3417, 2020 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32706640
10.
Correspondence comprehensive characterization of a brainstem aggregoma (light and heavy chain deposition disease).
Brain Pathol
; 33(5): e13154, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827605
11.
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.
JAMA Oncol
; 4(10): 1405-1409, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955793
12.
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.
JAMA Oncol
; 3(6): 784-792, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097324